EMA Nod For First MASH Drug Rezdiffra, Cell Therapy Zemcelpro And 11 Others

 
• By Eliza Slawther
The European medicines agency has given the green light to 13 new products for marketing authorization in the EU (Shutterstock)

More from EU CHMP

More from Rare Diseases